Repligen Historical Balance Sheet

RGEN Stock

USD 149.99 3.25 2.21%

Trend analysis of Repligen balance sheet accounts such as Total Stockholder Equity of 2.1 B, Property Plant And Equipment Net of 339.1 M, Retained Earnings of 460.8 M or Cash of 788.9 M provides information on Repligen's total assets, liabilities, and equity, which is the actual value of Repligen to its prevalent stockholders. By breaking down trends over time using Repligen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Repligen latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Repligen is a good buy for the upcoming year.

Repligen Inventory

212.44 Million

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

About Repligen Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Repligen at a specified time, usually calculated after every quarter, six months, or one year. Repligen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Repligen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Repligen currently owns. An asset can also be divided into two categories, current and non-current.

Repligen Balance Sheet Chart

At this time, Repligen's Retained Earnings are very stable compared to the past year. As of the 29th of November 2024, Cash is likely to grow to about 788.9 M, while Net Debt is likely to drop (41.5 M).

Short Long Term Debt Total Other Current Liab Total Current Liabilities Total Stockholder Equity Property Plant And Equipment Net

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on Repligen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Repligen are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Repligen's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Repligen current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.At this time, Repligen's Retained Earnings are very stable compared to the past year. As of the 29th of November 2024, Cash is likely to grow to about 788.9 M, while Net Debt is likely to drop (41.5 M).

	2021	2022	2023	2024 (projected)
Other Current Liabilities	70.5M	63.3M	46.4M	48.7M
Short and Long Term Debt Total	366.1M	423.0M	711.8M	747.4M

Other Current Liab Short Long Term Debt Total

Repligen balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Short Term Debt	Other Assets	Common Stock Total Equity	Short Term Investments
Total Assets		0.94	0.93	0.78	0.81	0.95	-0.38	0.93	0.96	0.97	0.11	0.97	0.97	0.61	0.82	0.96	0.95	0.91	0.97	0.94	0.99	0.86	0.49	0.36	0.78	0.12
Short Long Term Debt Total	0.94		0.79	0.57	0.89	0.95	-0.13	0.94	0.89	0.93	0.1	0.89	0.93	0.49	0.95	0.9	0.95	0.84	0.97	0.95	0.92	0.72	0.27	0.28	0.66	0.01
Other Current Liab	0.93	0.79		0.9	0.73	0.89	-0.43	0.84	0.86	0.93	0.13	0.88	0.95	0.73	0.64	0.95	0.86	0.9	0.89	0.87	0.92	0.97	0.69	0.24	0.81	0.23
Total Current Liabilities	0.78	0.57	0.9		0.48	0.72	-0.57	0.68	0.74	0.79	0.04	0.78	0.82	0.72	0.33	0.82	0.73	0.83	0.7	0.68	0.8	0.91	0.87	0.16	0.75	0.34
Total Stockholder Equity	0.81	0.89	0.73	0.48		0.85	0.01	0.83	0.73	0.82	0.11	0.72	0.85	0.33	0.86	0.81	0.91	0.77	0.87	0.88	0.77	0.71	0.23	0.27	0.5	-0.18
Property Plant And Equipment Net	0.95	0.95	0.89	0.72	0.85		-0.11	0.98	0.85	0.96	0.11	0.87	0.97	0.53	0.85	0.99	0.95	0.89	0.97	1.0	0.93	0.83	0.45	0.27	0.69	0.24
Net Debt	-0.38	-0.13	-0.43	-0.57	0.01	-0.11		-0.08	-0.56	-0.33	0.04	-0.54	-0.3	-0.59	0.02	-0.22	-0.25	-0.36	-0.24	-0.06	-0.46	-0.44	-0.48	-0.12	-0.58	0.18
Retained Earnings	0.93	0.94	0.84	0.68	0.83	0.98	-0.08		0.84	0.94	0.16	0.86	0.95	0.45	0.86	0.96	0.93	0.87	0.96	0.98	0.91	0.77	0.38	0.22	0.66	0.22
Cash	0.96	0.89	0.86	0.74	0.73	0.85	-0.56	0.84		0.94	0.13	1.0	0.92	0.66	0.79	0.86	0.9	0.86	0.94	0.83	0.98	0.81	0.43	0.23	0.84	-0.07
Non Current Assets Total	0.97	0.93	0.93	0.79	0.82	0.96	-0.33	0.94	0.94		0.2	0.96	0.99	0.64	0.84	0.97	0.95	0.91	0.99	0.94	0.98	0.88	0.48	0.14	0.82	0.08
Non Currrent Assets Other	0.11	0.1	0.13	0.04	0.11	0.11	0.04	0.16	0.13	0.2		0.13	0.15	0.01	0.2	0.14	0.11	0.2	0.17	0.11	0.14	0.1	-0.02	-0.33	0.18	-0.17
Cash And Short Term Investments	0.97	0.89	0.88	0.78	0.72	0.87	-0.54	0.86	1.0	0.96	0.13		0.94	0.68	0.78	0.89	0.91	0.88	0.94	0.85	0.99	0.82	0.47	0.25	0.84	0.01
Net Receivables	0.97	0.93	0.95	0.82	0.85	0.97	-0.3	0.95	0.92	0.99	0.15	0.94		0.65	0.81	0.98	0.96	0.93	0.98	0.96	0.97	0.91	0.55	0.2	0.79	0.13
Common Stock Shares Outstanding	0.61	0.49	0.73	0.72	0.33	0.53	-0.59	0.45	0.66	0.64	0.01	0.68	0.65		0.33	0.62	0.51	0.59	0.57	0.49	0.68	0.73	0.63	-0.05	0.89	0.16
Non Current Liabilities Total	0.82	0.95	0.64	0.33	0.86	0.85	0.02	0.86	0.79	0.84	0.2	0.78	0.81	0.33		0.78	0.84	0.68	0.91	0.87	0.8	0.55	-0.01	0.19	0.55	-0.15
Inventory	0.96	0.9	0.95	0.82	0.81	0.99	-0.22	0.96	0.86	0.97	0.14	0.89	0.98	0.62	0.78		0.93	0.92	0.96	0.97	0.94	0.9	0.58	0.22	0.75	0.29
Other Current Assets	0.95	0.95	0.86	0.73	0.91	0.95	-0.25	0.93	0.9	0.95	0.11	0.91	0.96	0.51	0.84	0.93		0.94	0.96	0.94	0.94	0.82	0.46	0.29	0.69	0.0
Other Stockholder Equity	0.91	0.84	0.9	0.83	0.77	0.89	-0.36	0.87	0.86	0.91	0.2	0.88	0.93	0.59	0.68	0.92	0.94		0.89	0.87	0.91	0.85	0.68	0.23	0.72	0.15
Total Liab	0.97	0.97	0.89	0.7	0.87	0.97	-0.24	0.96	0.94	0.99	0.17	0.94	0.98	0.57	0.91	0.96	0.96	0.89		0.96	0.97	0.83	0.38	0.22	0.76	0.04
Property Plant And Equipment Gross	0.94	0.95	0.87	0.68	0.88	1.0	-0.06	0.98	0.83	0.94	0.11	0.85	0.96	0.49	0.87	0.97	0.94	0.87	0.96		0.9	0.81	0.42	0.27	0.66	0.22
Total Current Assets	0.99	0.92	0.92	0.8	0.77	0.93	-0.46	0.91	0.98	0.98	0.14	0.99	0.97	0.68	0.8	0.94	0.94	0.91	0.97	0.9		0.87	0.51	0.24	0.84	0.07
Accounts Payable	0.86	0.72	0.97	0.91	0.71	0.83	-0.44	0.77	0.81	0.88	0.1	0.82	0.91	0.73	0.55	0.9	0.82	0.85	0.83	0.81	0.87		0.72	0.17	0.78	0.18
Short Term Debt	0.49	0.27	0.69	0.87	0.23	0.45	-0.48	0.38	0.43	0.48	-0.02	0.47	0.55	0.63	-0.01	0.58	0.46	0.68	0.38	0.42	0.51	0.72		0.11	0.5	0.47
Other Assets	0.36	0.28	0.24	0.16	0.27	0.27	-0.12	0.22	0.23	0.14	-0.33	0.25	0.2	-0.05	0.19	0.22	0.29	0.23	0.22	0.27	0.24	0.17	0.11		-0.01	0.2
Common Stock Total Equity	0.78	0.66	0.81	0.75	0.5	0.69	-0.58	0.66	0.84	0.82	0.18	0.84	0.79	0.89	0.55	0.75	0.69	0.72	0.76	0.66	0.84	0.78	0.5	-0.01		0.05
Short Term Investments	0.12	0.01	0.23	0.34	-0.18	0.24	0.18	0.22	-0.07	0.08	-0.17	0.01	0.13	0.16	-0.15	0.29	0.0	0.15	0.04	0.22	0.07	0.18	0.47	0.2	0.05

Click cells to compare fundamentals

Repligen Account Relationship Matchups

Repligen balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.4B	1.9B	2.4B	2.5B	2.8B	3.0B
Short Long Term Debt Total	263.3M	275.4M	366.1M	423.0M	711.8M	747.4M
Other Current Liab	28.3M	36.3M	70.5M	63.3M	46.4M	48.7M
Total Current Liabilities	48.3M	319.0M	375.3M	404.2M	158.2M	166.1M
Total Stockholder Equity	5.8M	65.8M	1.8B	397.3M	2.0B	2.1B
Property Plant And Equipment Net	74.2M	92.0M	226.5M	315.7M	323.0M	339.1M
Net Debt	(265.1M)	(441.9M)	(237.8M)	(100.5M)	(39.5M)	(41.5M)
Retained Earnings	5.8M	65.8M	194.1M	397.3M	438.8M	460.8M
Cash	528.4M	717.3M	603.8M	523.5M	751.3M	788.9M
Non Current Assets Total	758.3M	1.0B	1.4B	1.5B	1.7B	1.8B
Non Currrent Assets Other	238K	573K	615K	815K	1.3M	1.3M
Cash And Short Term Investments	528.4M	717.3M	603.8M	623.8M	751.3M	788.9M
Net Receivables	43.7M	71.4M	117.4M	116.2M	124.2M	130.4M
Common Stock Shares Outstanding	49.2M	53.9M	57.3M	57.5M	56.4M	29.9M
Liabilities And Stockholders Equity	346.2M	439.5M	2.4B	1.0B	2.8B	3.0B
Non Current Liabilities Total	292.0M	54.8M	233.0M	209.8M	695.0M	729.8M
Inventory	54.8M	95.0M	184.5M	238.3M	202.3M	212.4M
Other Current Assets	3.1M	18.7M	25.9M	19.8M	33.2M	34.9M
Other Stockholder Equity	14.5M	1.5B	1.6B	1.5B	1.6B	1.6B
Total Liab	340.3M	373.7M	608.3M	614.0M	853.2M	895.9M
Property Plant And Equipment Gross	74.2M	92.0M	297.2M	408.0M	451.7M	474.3M
Total Current Assets	641.8M	902.4M	931.7M	998.1M	1.1B	1.2B
Accumulated Other Comprehensive Income	(15.0M)	2.1M	(16.9M)	(34.4M)	(37.4M)	(35.6M)
Accounts Payable	11.4M	16.9M	36.2M	27.6M	19.6M	20.5M
Short Term Debt	3.6M	249.0M	263.6M	291.6M	75.1M	101.1M
Other Assets	3.2M	28.2M	2.5M	1.7M	1.5M	1.6M
Common Stock Total Equity	521K	548K	553K	556K	639.4K	389.2K
Common Stock	521K	548K	553K	556K	558K	398.5K
Property Plant Equipment	48.5M	66.9M	125.0M	190.7M	219.3M	230.2M
Other Liab	32.3M	28.4M	130.5M	78.4M	90.1M	94.6M
Current Deferred Revenue	5.0M	15.3M	14.8M	19.3M	10.3M	5.4M
Good Will	468.4M	618.3M	860.4M	855.5M	987.1M	1.0B
Intangible Assets	212.6M	287.1M	337.3M	353.7M	400.5M	420.5M
Net Tangible Assets	378.8M	623.7M	552.4M	701.5M	806.7M	847.1M
Retained Earnings Total Equity	5.8M	65.8M	194.1M	397.3M	456.9M	479.7M
Capital Surpluse	1.1B	1.5B	1.6B	1.5B	1.8B	1.9B

Pair Trading with Repligen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.

The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:

How To Invest In Repligen

Details

Is Repligen Stock a good investment?

Details

What is Repligen's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.83)

Earnings Share

(0.03)

Revenue Per Share

11.452

Quarterly Revenue Growth

0.097

Return On Assets

0.002

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Repligen Historical Balance Sheet

Repligen Inventory

212.44 Million

About Repligen Balance Sheet Analysis

Repligen Balance Sheet Chart

Total Current Liabilities

Total Stockholder Equity

Property Plant And Equipment Net

Repligen balance sheet Correlations

Repligen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Repligen balance sheet Accounts

Pair Trading with Repligen

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Inventory	+ 0.99	Property Plant And Equipment Net
Net Receivables	+ 0.99	Non Current Assets Total
Total Liab	+ 0.99	Non Current Assets Total

Common Stock Shares Outstanding	- 0.59	Net Debt
Common Stock Total Equity	- 0.58	Net Debt
Net Debt	- 0.57	Total Current Liabilities
Cash	- 0.56	Net Debt
Cash And Short Term Investments	- 0.54	Net Debt
Short Term Debt	- 0.48	Net Debt